Article Text

Download PDFPDF
Rare neonatal interstitial lung disease masquerading as pulmonary hemosiderosis
  1. Viraraghavan Vadakkencherry Ramaswamy1,
  2. Sushma Nangia2,
  3. Anu Thukral3 and
  4. Varinder Singh4
  1. 1 Department of Neonatology, Nori Multispeciality Hospital, Vijayawada, India
  2. 2 Department of Neonatology, Lady Hardinge Medical College, New Delhi, India
  3. 3 Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
  4. 4 Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India
  1. Correspondence to Dr Viraraghavan Vadakkencherry Ramaswamy, 19.viraram{at}


A preterm 32-week neonate presented on the 14th day of life with respiratory distress and cyanosis. The respiratory distress worsened progressively, which was managed with continuous positive airway pressure support. The neonate had blood-tinged oral secretions on the 39th day of life, for which bronchoscopy was performed, whose findings were suggestive of pulmonary hemosiderosis. Lung biopsy confirmed the diagnosis of pulmonary interstitial glycogenosis with pulmonary arterial hypertension. The neonate was treated successfully with systemic corticosteroids and discharged home at 3 months of age.

  • paediatrics
  • infant health
  • neonatal and paediatric intensive care
  • neonatal health

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors VVR was involved in the clinical care of the patient and in writing the manuscript. SN supervised the manuscript writing. AT was involved in the clinical care of the patient and in reviewing the manuscript. VS performed the lung biopsy and guided in the management of the the case.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Parental/guardian consent was obtained.